Start the conversation
When we talked last Wednesday, I told you about three tech leaders whose stocks are quickly rebounding - giving you three solid ways to profit following the market's recent retreat.
I also promised to reveal a fourth investment that could add to your net worth over the long haul. Today I'm going to make good on that promise.
This investment takes advantage of one of the biggest trends in tech right now - the rapid consolidation of the semiconductor industry.
In fact, a new Dealogic report says that chip firms have announced $100.6 billion in mergers and acquisitions (M&A) so far this year - more than triple the $37.7 billion for all of 2014. And we've still two months to go in 2015.
But there's much more to this story than just dollar volume.
A very important facet of these deals has gone largely unnoticed.
Today I'll show you a great way to play this historic chip M&A boom using an investment you'll want to own for the long haul.
And I'll also tell what that "secret" detail is...
According to Dealogic, last year saw 369 M&A deals. This year, the number of transactions has dipped about 25% to 276.
While there are fewer deals this year, if you only focus on the raw number of deals, you'll miss the real story: the sheer size of many of this year's M&A deals.
In fact, what's going on is so profound that I believe that, for the semiconductor industry at least, 2015 will go down as "Year of the Mega-Merger."
Last year, the average chip M&A deal booked a value of $102 million, while this year, the average deal is more than three times as large - $364.5 million.
And IC Insights reports that in the first half of this year alone, the average deal was about six times larger than the average deal size over the 2010-2014 period.
And even those comparisons understate the true scale of things. Take a look at a sample of some recent M&A.
On Oct. 21, disk-drive maker Western Digital Corp. (Nasdaq: WDC) agreed to buy SanDisk Corp. (Nasdaq: SNDK) for about $19 billion in cash and stock. SanDisk specializes in chips used to store computer data.
Around that same time, the industry saw the largest deal so far this year when Avago Technologies Ltd. (Nasdaq: AVGO) said it's buying rival Broadcom Corp. (Nasdaq: BRCM) in a deal valued at $37 billion in cash and stock.
What's Driving the Tech M&A Boom
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.